Morphological regeneration and hepatic functional mass after right hemihepatectomy

Digestive Surgery

Volumn 23, Issue 1-2, 2006, Pages 44-50

  Kobayashi, Takashi ^a,b,c   Imamura, Hiroshi ^b   Aoki, Taku ^b   Sugawara, Yasuhiko ^b   Kokudo, Norihiro ^b   Makuuchi, Masatoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kodaira shi   (Japan)

Author keywords

Hepatic functional mass; Intrinsic clearance of antipyrine; Liver regeneration; Morphological regeneration

Indexed keywords

PHENAZONE;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTROLLED STUDY; FEMALE; HEMIHEPATECTOMY; HUMAN; LIVER CLEARANCE; LIVER FUNCTION; LIVER ISCHEMIA; LIVER REGENERATION; LIVER SIZE; LIVER WEIGHT; MALE; OPERATION DURATION; ORGAN DONOR; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SAMPLE SIZE;

ADOLESCENT; ADULT; ANTIPYRINE; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER REGENERATION; LIVING DONORS; MALE; MIDDLE AGED; ORGAN SIZE;

EID: 33746801926     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093754     Document Type: Article

References (32)

1. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60-66.
2. Wieser W: Cost of growth in cells and organisms: general rules and comparative aspects. Biol Rev Camb Philos Soc 1994;69:1-33.
3. Francavilla A, Panella C, Polimeno L, Giangaspero A, Mazzaferro V, Pan CE, Van Thiel DH, Starzl TE: Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections. Hepatology 1990;12:1134-1138.
4. Mann DV, Lam WW, Hjelm NM, So NM, Yeung DK, Metreweli C, Lau WY: Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology 2001;34:557-565.
5. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T: Human liver regeneration after major hepatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987;206:30-39.
6. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO: Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135:336-340.
7. Surman OS: The ethics of partial-liver donation. N Engl J Med 2002;346:1038.
8. Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M: Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med 1979;90:185-187.
9. Kawasaki S, Imamura H, Bandai Y, Sanjo K, Idezuki Y: Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology 1992;102:1351-1355.
10. Villeneuve JP, Gerber JG, Branch RA, Shand DG, Wilson JT: Drug metabolism in rats bearing a pituitary mammotropic tumor. J Pharmacol Exp Ther 1979;209:7-11.
11. Fisher B, Szuch P, Levine M, Fisher ER: A portal blood factor as the humoral agent in liver regeneration. Science 1971;171:575-577.
12. Starzl TE, Porter KA, Kashiwagi N: Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet 1975;141:843-858.
13. Rosenberg PM, Friedman LS: The liver in circulatory failure; in Schiff ER, Sorrell MF, Maddrey WC (eds): Schiffs Diseases of the Liver, ed 8. Philadelphia, Lippincott-Raven, 1999, pp 1215-1227.
14. Millikan WJ Jr, Henderson JM, Stewart MT, Warren WD, Marsh JW, Galloway JR, Jennings H, Kawasaki S, Dodson TF, Perlino CA, Hertzler GL, Hooks MA, Smith SL, Moore PB: Change in hepatic function, hemodynamics, and morphology after liver transplant: physiological effect of therapy. Ann Surg 1989;209:513-525.
15. Kawasaki S, Makuuchi M, Ishizone S, Matsunami H, Terada M, Kawarazaki H: Liver regeneration in recipients and donors after transplantation. Lancet 1992;339:580-581.
16. Nishizaki T, Ikegami T, Hiroshige S, Hashimoto K, Uchiyama H, Yoshizumi T, Kishikawa K, Shimada M, Sugimachi K: Small graft for living donor liver transplantation. Ann Surg 2001;233:575-580.
17. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, Furukawa K, Tanaka T, Tomoda F, Tanaka W: Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993;18:79-85.
18. Gao L, Ramzan I, Baker AB: Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery. Anaesth Intens Care 2000;28:375-385.
19. Brodie BB, Axelrod J: The fate of antipyrine in man. J Pharmacol Exp Ther 1950;98:97-104.
20. Andreasen PB, Ranek L, Statland BE, Tygstrup N: Clearance of antipyrine-dependence of quantitative liver function. Eur J Clin Invest 1974;4:129-134.
21. Kawasaki S, Sugiyama Y, Iga T, Hanano M, Beppu T, Sugiura M, Sanjo K, Idezuki Y: Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases. Clin Pharmacol Ther 1988;44:217-224.
22. Mehta MU, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Yang SL, Gray JA, Van Thiel DH, Starzl TE: Antipyrine kinetics in liver disease and liver transplantation. Clin Pharmacol Ther 1986;39:372-377.
23. Burnett DA, Barak AJ, Tuma DJ, Sorrell MF: Altered elimination of antipyrine in patients with acute viral hepatitis. Gut 1976;17:341-344.
24. Shimada R, Imamura H, Nakayama A, Miyagawa S, Kawasaki S: Changes in blood flow and function of the liver after right portal vein embolization. Arch Surg 2002;137:1384-1388.
25. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Fulcher AS, Posner MP: Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379.
26. Hashimoto M, Sanjo K: Functional capacity of the liver after two-thirds partial hepatectomy in the rat. Surgery 1997;121:690-697.
27. Poulsen HE: One sample antipyrine clearance after 90% partial hepatectomy in the rat. Liver 1985;5:200-204.
28. Poulsen HE, Pilsgaard H: Antipyrine metabolism during hepatic regeneration in the rat. Liver 1985;5:196-199.
29. Galtier M, Briand D, Pinguet F, Gomeni R, Fabre D, Bressolle F: Pharmacokinetic parameters of antipyrine in dog after hepatectomy. Biopharm Drug Dispos 1995;16:669-684.
30. Imamura H, Takayama T, Sugawara Y, Kokudo N, Aoki T, Kaneko J, Matsuyama Y, Sano K, Maema A, Makuuchi M: Pringle's manoeuvre in living donors. Lancet 2002;360:2049-2050.
31. Clavien PA, Yadav S, Sindram D, Bentley RC: Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000;232:155-162.
32. Minard G, Bynoe R, Wood GC, Fabian TC, Croce M, Kudsk KA: Effect of isolated hepatic ischemia on organic anion clearance and oxidative metabolism. J Trauma 1992;32:514-518.